RadNet FCF Yield
The Free Cash Flow Yield of RadNet (RDNT) as of Jul 7, 2026 is 0.01.In the previous year, Free Cash Flow Yield was 0.01 — a change of 1.56% (higher).
Get this data via API
Financial Data API
FCF Yield
0.01
YoY
1.56%
Last updated:
Free Cash Flow Yield of RadNet is 2026 0.01 . Free Cash Flow Yield of RadNet was 2025 0.01 . It decreases by 1.56% higher compared to the previous year.
Access this data via the Eulerpool API
RadNet Stock analysis
What does RadNet do? RadNet Inc is a leading company in the field of diagnostic imaging in the United States. The company was founded in 1985 and has since undergone impressive development. Today, RadNet operates the largest network of diagnostic imaging centers in the United States and offers a comprehensive range of diagnostic and therapeutic procedures.
RadNet's business model is focused on providing high-quality diagnostic imaging services at competitive prices. The company generates most of its revenue by providing imaging services to Medicare patients and private patients funded by insurers and employers. RadNet also offers its services directly to healthcare facilities, including physician practices, hospitals, and clinics.
RadNet offers a wide range of diagnostic imaging services, including X-rays, CT scans, MRI scans, and nuclear medicine procedures. The company also offers specialized imaging services, including mammography, ultrasound, and PET-CT. RadNet, along with its partners, also provides radiation therapy and other cancer treatments.
In recent years, RadNet has also experienced strong development in the field of telemedicine and artificial intelligence (AI). An AI-based image processing platform has been developed to assist in the detection of cancer and other diseases. The platform uses innovative algorithms to read and analyze imaging results faster and more accurately.
The company has also conducted a series of acquisitions in recent years to strengthen its position in the field of diagnostic imaging. In 2017, the company acquired Doshi Diagnostics Imaging Services, which operated in New York City. In 2018, the company entered into a long-term partnership with Florida-based Diagnostic Centers of America (DCA), and in 2020, the company acquired Elite Imaging of South Florida LLC. These acquisitions have helped RadNet strengthen its presence in core markets and expand its reach into new areas.
RadNet has also made a name for itself by developing innovative technology and new models of collaboration. The company has a firm place in the healthcare and research world, working together with respected health systems, academies, and universities to find new ways to diagnose and treat diseases.
In summary, RadNet Inc is a leading company in the field of diagnostic imaging. The company offers high-quality and innovative services tailored to the needs of patients, physicians, and healthcare facilities. RadNet remains committed to achieving the best possible outcomes for its customers and further expanding its position in the market. RadNet is one of the most popular companies on Eulerpool.
Frequently Asked Questions about RadNet stock
Free Cash Flow Yield of RadNet amounted to 0.01 0.01
Access this data via the Eulerpool API
Valuation — RadNet
All Key Metrics — RadNet
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth